This pharmacological probe (CH004, Fig. 5a) allows selective inhibition of CBS (raising cellular homocysteine levels and suppressing the production of H2S in a dose-dependent manner) over CSE; it can suppress cell proliferation with cell cycle arrest at S phase and, notably, it can reduce tumour growth in a xenograft mouse model. This evidence concerns the gene CBS and neoplasm.